• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Application of the Next-Generation Sequencing Technology to Reveal Mechanism of Small Cell Lung Cancer Transformation from Adenocarcinoma.

作者信息

Zhou Yong-Zhao, Jin Jing, Tian Pan-Wen, Li Wei-Min

机构信息

Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.

出版信息

Chin Med J (Engl). 2018 May 5;131(9):1124-1125. doi: 10.4103/0366-6999.230720.

DOI:10.4103/0366-6999.230720
PMID:29692390
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5937328/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a27a/5937328/e32db7749e8b/CMJ-131-1124-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a27a/5937328/e32db7749e8b/CMJ-131-1124-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a27a/5937328/e32db7749e8b/CMJ-131-1124-g001.jpg

相似文献

1
Application of the Next-Generation Sequencing Technology to Reveal Mechanism of Small Cell Lung Cancer Transformation from Adenocarcinoma.应用新一代测序技术揭示腺癌转化为小细胞肺癌的机制。
Chin Med J (Engl). 2018 May 5;131(9):1124-1125. doi: 10.4103/0366-6999.230720.
2
Next-Generation Sequencing of Endobronchial Ultrasound Transbronchial Needle Aspiration Specimens in Lung Cancer.肺癌中经支气管超声引导针吸活检标本的下一代测序
Am J Respir Crit Care Med. 2017 Aug 1;196(3):388-391. doi: 10.1164/rccm.201609-1935LE.
3
A Case of ALK-Rearranged Adenocarcinoma with Small Cell Carcinoma-Like Transformation and Resistance to Crizotinib.ALK 重排腺癌伴小细胞癌样转化及对克唑替尼耐药 1 例报告
J Thorac Oncol. 2016 May;11(5):e55-e58. doi: 10.1016/j.jtho.2015.12.097. Epub 2015 Dec 29.
4
Transformation to "high grade" neuroendocrine carcinoma as an acquired drug resistance mechanism in EGFR-mutant lung adenocarcinoma.作为 EGFR 突变型肺腺癌获得性耐药机制的“高级别”神经内分泌癌转化。
Lung Cancer. 2013 Apr;80(1):1-4. doi: 10.1016/j.lungcan.2012.12.019. Epub 2013 Jan 10.
5
The molecular approach to diagnosis in lung cancer.肺癌诊断的分子方法。
Br J Hosp Med (Lond). 2015 May;76(5):C74-6. doi: 10.12968/hmed.2015.76.5.C74.
6
[Report of epidermal growth factor receptor mutation in a patient with combined small cell lung cancer].[一例小细胞肺癌合并表皮生长因子受体突变的报告]
Zhonghua Bing Li Xue Za Zhi. 2014 Jan;43(1):45-6.
7
Spontaneous Transdifferentiation from Small Cell Lung Carcinoma to Squamous Cell Carcinoma.小细胞肺癌向鳞状细胞癌的自发转分化
J Thorac Oncol. 2019 Feb;14(2):e31-e34. doi: 10.1016/j.jtho.2018.10.159.
8
Hotspot Mutations Detectable by Next-generation Sequencing in Exhaled Breath Condensates from Patients with Lung Cancer.通过下一代测序在肺癌患者呼出气冷凝物中可检测到的热点突变。
Anticancer Res. 2018 Oct;38(10):5627-5634. doi: 10.21873/anticanres.12897.
9
Lack of response to nivolumab in a patient with EGFR-mutant non-small cell lung cancer adenocarcinoma sub-type transformed to small cell lung cancer.一名表皮生长因子受体（EGFR）突变的非小细胞肺癌腺癌亚型转化为小细胞肺癌的患者对纳武单抗无反应。
Lung Cancer. 2017 Sep;111:65-68. doi: 10.1016/j.lungcan.2017.07.012. Epub 2017 Jul 11.
10
Small-cell carcinoma in the setting of pulmonary adenocarcinoma: new insights in the era of molecular pathology.肺腺癌中小细胞癌：分子病理时代的新认识。
J Thorac Oncol. 2013 Oct;8(10):1265-71. doi: 10.1097/JTO.0b013e3182a407fa.

引用本文的文献

1
Transformation to Neuroendocrine Phenotype in Non-Small-Cell Lung Carcinoma: A Literature Review.非小细胞肺癌向神经内分泌表型的转变：文献综述
Int J Mol Sci. 2025 May 26;26(11):5096. doi: 10.3390/ijms26115096.
2
Increasing cisplatin exposure promotes small-cell lung cancer transformation after a shift from glucose metabolism to fatty acid metabolism.在从小鼠的葡萄糖代谢转变为脂肪酸代谢后，增加顺铂暴露会促进小细胞肺癌的转化。 （注：原文中未明确说明是小鼠，根据上下文推测可能是小鼠，若不是请根据实际情况修改）
J Cancer Res Clin Oncol. 2025 Mar 28;151(3):126. doi: 10.1007/s00432-025-06164-3.
3
Small cell lung cancer transformations from non-small cell lung cancer: Biological mechanism and clinical relevance.

本文引用的文献

1
Primary resistance to osimertinib due to SCLC transformation: Issue of T790M determination on liquid re-biopsy.奥希替尼治疗原发性耐药导致小细胞肺癌转化：液体再活检T790M 检测问题。
Lung Cancer. 2018 Jan;115:21-27. doi: 10.1016/j.lungcan.2017.11.011. Epub 2017 Nov 13.
2
Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin.非小细胞肺癌向小细胞肺癌的转变：分子驱动因素及起源细胞
Lancet Oncol. 2015 Apr;16(4):e165-72. doi: 10.1016/S1470-2045(14)71180-5.
3
Identification of cancer initiating cells in K-Ras driven lung adenocarcinoma.
非小细胞肺癌向小细胞肺癌的转化：生物学机制及临床意义。
Chin Med J Pulm Crit Care Med. 2024 Feb 6;2(1):42-47. doi: 10.1016/j.pccm.2023.10.005. eCollection 2024 Mar.
4
Case report: Acute pancreatitis in lung adenocarcinoma with small cell transformation after multiple line targeted therapy.病例报告：多线靶向治疗后发生小细胞转化的肺腺癌合并急性胰腺炎
Front Oncol. 2024 Jan 19;14:1274034. doi: 10.3389/fonc.2024.1274034. eCollection 2024.
鉴定 K-Ras 驱动的肺腺癌中的癌症起始细胞。
Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):255-60. doi: 10.1073/pnas.1320383110. Epub 2013 Dec 23.
4
Cell of origin of small cell lung cancer: inactivation of Trp53 and Rb1 in distinct cell types of adult mouse lung.小细胞肺癌的起源细胞：成年小鼠肺部不同细胞类型中 Trp53 和 Rb1 的失活。
Cancer Cell. 2011 Jun 14;19(6):754-64. doi: 10.1016/j.ccr.2011.04.019.